^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    AEZS-129

    i

    Associations

    News
    Trials
    Company:
    COSCIENS Biopharma
    Drug class:
    PI3K inhibitor, ERK inhibitor
    Related drugs:

    Associations

    News
    Trials